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Mammalian aging is associated with reduced tissue regeneration, increased degenerative disease, and
cancer. Because stem cells regenerate many adult tissues and contribute to the development of cancer
by accumulating mutations, age-related changes in stem cells likely contribute to age-related morbidity.
Consistent with this, stem cell function declines with age in numerous tissues as a result of gate-keeping
tumor suppressor expression, DNA damage, changes in cellular physiology, and environmental changes in
tissues. It remains unknown whether declines in stem cell function during aging influence organismal
longevity. However, mechanisms that influence longevity also modulate age-related morbidity, partly
through effects on stem cells.Introduction
Damage accumulates in biological macromolecules during
aging, impairing cellular processes, tissue homeostasis, and
organ function. This contributes to the onset of age-related
diseases, including cognitive (Yankner et al., 2008), neoplastic
(Hoeijmakers, 2009), immunologic (Dorshkind et al., 2009), and
metabolic (Wallace, 2005) disorders. Age-related morbidity is
determined partly by changes in nondividing differentiated cells,
such as neurons (Lu et al., 2004), and partly by changes inmitotic
cells, including stem cells, restricted progenitors, and differenti-
ated cells (Sharpless and DePinho, 2007).
Stem cells persist throughout life in numerous mammalian
tissues, replacing cells lost to homeostatic turnover, injury, and
disease. However, stem cell function declines with age in
a number of tissues, including the blood (Morrison et al.,
1996b; de Haan et al., 1997; Chen et al., 2000), forebrain (Kuhn
et al., 1996; Maslov et al., 2004; Molofsky et al., 2006), skeletal
muscle (Conboy et al., 2003, 2005), and skin (Nishimura et al.,
2005) (Table 1). These declines in stem cell function may
contribute to degeneration and dysfunction in aging regenerative
tissues (Sharpless and DePinho, 2007). Thus, age-related
changes in the function of stem cells and other progenitors
may contribute to some diseases of aging, particularly in regen-
erative tissues, even while other diseases of aging may not be
influenced by stem cell aging at all.
It is unknown whether stem cell aging influences mammalian
life span. However, in Drosophila genetic changes that improve
homeostasis in the intestinal epithelium by blocking stem cell
overproliferation and differentiation defects during aging do
extend life span (Biteau et al., 2010). This raises the possibility
that some age-related changes in mammalian stem cells
promote homeostasis in aging tissues despite declines in stem
cell function.
It is important to emphasize that stem cells are not the only
mitotic cells that persist throughout life and whose aging might
influence age-related diseases. Like stem cells, some restricted
progenitors and differentiated cells are also perpetuated
throughout life by intermittent self-renewing divisions. Such cells152 Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc.include pancreatic b cells and memory B and T cells. During
aging, declines in the number or function of pancreatic b cells
(Teta et al., 2005) and memory T cells (Liu et al., 2011) contribute
to the development of type 2 diabetes (Butler et al., 2003) and
reduced immune function (Dorshkindet al., 2009). There is at least
some overlap in self-renewal mechanisms between these differ-
entiated cells and stem cells (Luckey et al., 2006). This suggests
that some of the mechanisms that regulate stem cell aging may
also regulate the aging of mitotic differentiated cells, and both
classes of progenitors may contribute to age-related morbidity.
Stem cells must change their properties throughout life to
match the changing growth and regeneration demands of
tissues. Stem cells divide rapidly during fetal development to
support rapid growth. By young adulthood, growth has slowed
or ceased in mammalian tissues and most stem cells are quies-
cent most of the time, intermittently dividing to maintain tissue
homeostasis. In old adults, stem cells increase gate-keeping
tumor suppressor expression. This may reduce the incidence
of cancer in aging tissues, but also reduces regenerative
capacity (Janzen et al., 2006; Krishnamurthy et al., 2006; Molof-
sky et al., 2006). These changes in stem cells likely reflect
regulation by heterochronic genes—genes whose expression
changes over time in a way that causes temporal changes in
stem cell function (Nishino et al., 2008; Toledano et al., 2012).
Heterochronic genes were originally identified as regulating the
timing of developmental transitions in C. elegans (Ambros and
Horvitz, 1984). This raises the question of whether the increase
in tumor suppressor expression and the temporal changes in
stem cell function in aging mammalian tissues are partly devel-
opmentally programmed.
Mitochondrial activity, tissue growth, and metabolic rates
during development can also influence life span and the rates
of cellular aging at later stages of life (Dillin et al., 2002). Thus,
the aging of stem cells cannot be considered in isolation but
rather in the context of temporal changes in stem cell and tissue
properties that occur throughout life.
Like all cells, stem cell aging is determined partly by the accu-
mulation of damage over time. Declines in stem cell function
Table 1. Summary of Age-Related Changes in Various Mammalian Stem Cell Populations
Stem Cell Population Frequency Proliferation Differentiation Other Defects
Hematopoietic [ long-lived mouse strains,
Y short-lived mouse strains
[ cycling,
Y self-renewal
Y lymphoid, [ myeloid Y homing, Y mobilization,
Y engraftment,
Neural Y lateral ventricle SVZ,
Y dentate gyrus subgranular layer
Y cycling,
Y self-renewal (SVZ)
Y neurogenesis,
[ gliogenesis
Muscle Y satellite cells associated
with muscle fibers
Y proliferation Y myogenic, [ fibrogenic,
[ adipogenic
Melanonocyte stem
cells in hair bulge
Y melanocyte stem cells [ terminal differentiation
of melanocytes
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damage, and mitochondrial damage (Choudhury et al., 2007;
Rossi et al., 2007; Sahin and Depinho, 2010) (Figure 1).
Stem cell aging can be slowed by dietary restriction (Lee et al.,
2000; Chen et al., 2003; Mair et al., 2010; Cerletti et al., 2012)
and by exposure to humoral factors from a young parabiont
(sharing circulation with an old mouse) (Conboy et al., 2005;
Villeda et al., 2011). In this review we discuss all of these mech-
anisms that influence stem cell aging in the context of mecha-
nisms that are known to influence general cellular aging and
life span.
Gate-Keeping Tumor Suppressors
Gate-keeping tumor suppressors (such as p16Ink4a, p19Arf, and
p53—see Figure 2) negatively regulate cellular proliferation and
survival (Kinzler and Vogelstein, 1997). These gene products
were first discovered by virtue of their role in cancer, but
probably evolved to regulate homeostasis in normal tissues
by regulating the proliferation and survival of normal cells.
Their role in cancer reflects the ability of cancer cells to evade
normal homeostatic controls by deleting these genes. Gate-
keeping tumor suppressors tend to negatively regulate stem
cell function (He et al., 2009) and regulate stem cell aging
because their expression and/or function increase with age
(Krishnamurthy et al., 2004, 2006; Janzen et al., 2006; Molofsky
et al., 2006).
A regulatory pathway of heterochronic genes increases gate-
keeping tumor suppressor expression in aging stem cells
(Figure 2A). let-7microRNA expression increaseswith age, prob-
ably inmany types of stem cells, eliminating the expression of the
high mobility group transcriptional regulator, Hmga2, in stem
cells from old mice (Nishino et al., 2008). Hmga2 is a proto-onco-
gene and let-7 target. The loss of Hmga2 expression from neural
stem cells reduces their frequency and self-renewal potential by
increasing the expression of p16Ink4a and p19Arf (Nishino et al.,
2008). p16Ink4a is a cyclin-dependent kinase inhibitor (Figure 2B)
whose expression increases in aging mouse and human tissues
(Krishnamurthy et al., 2004), reducing stem cell frequency and
self-renewal potential in multiple tissues (Janzen et al., 2006;
Krishnamurthy et al., 2006; Molofsky et al., 2006). Elevated
p16Ink4a expression also depletes certain differentiated progen-
itors during aging, including pancreatic b cells (Krishnamurthy
et al., 2006) and memory T cells (Liu et al., 2011).
p19Arf (p14Arf in humans) also increases with age in mouse
tissues (Zindy et al., 1997; Krishnamurthy et al., 2004). p19Arf
promotes p53 protein stability by inhibiting Mdm2-mediateddegradation (Figure 2B). It has not yet been tested whether
p19Arf negatively regulates stem cell function in aging tissues.
Beyond the mechanisms described above, there are likely to
be a number of other mechanisms that regulate changes in
p16Ink4a and p19Arf expression during aging, including yet undis-
covered mechanisms. A decline in the expression of the poly-
comb complex component, Ezh2, contributes to increased
p16Ink4a and p19Arf expression in aging pancreatic b cells
(Chen et al., 2009b). Whether a change in polycomb complex
activity contributes generally to changes in p16Ink4a and p19Arf
expression in aging stem cells remains untested.
The increase in gate-keeping tumor suppressor expression in
aging tissues, and the onset of senescence in some aging cells,
may oppose the increased incidence of cancer during aging
(Campisi, 2005; Signer et al., 2008). Indeed, p16Ink4a and/or
p19Arf deficiency increase the incidence of cancer in adult
mice (Serrano et al., 1996; Kamijo et al., 1997), and humans
with germline loss-of-function mutations in p16Ink4a/p14Arf have
more adult-onset cancers (Ruas and Peters, 1998). However, it
remains unclear whether the physiological increase in p16Ink4a
and p19Arf expression in aging cells suppresses cancer or
whether an even higher level of p16Ink4a and p19Arf expression,
induced by oncogenic stimuli, is responsible for cancer suppres-
sion. Transgenic mice with an extra copy of the p16Ink4a/p19Arf/
p15Ink4b and p53 loci have a lower cancer incidence, though
this may reflect the inability of cancer cells to delete the extra
copy of the locus rather than the modestly increased expression
of these tumor suppressors under physiological conditions (Gar-
cı´a-Cao et al., 2002; Matheu et al., 2004, 2007).
While p53 expression promotes the maintenance of genomic
integrity (Schoppy et al., 2010), the net effect of p53 in a wild-
type background is to negatively regulate stem cell function, at
least in hematopoietic stem cells (HSCs) from young adult
mice (TeKippe et al., 2003), presumably by opposing cell cycle
entry, blocking symmetric division, or inducing cell death (Cical-
ese et al., 2009; Liu et al., 2009b) (Figure 2 and Figure 3). Elevated
p53 expression or constitutive p53 activation can deplete stem
cells (Lee et al., 2010), cause premature aging, and shorten life
span despite reducing cancer incidence (Tyner et al., 2002;
Dumble et al., 2007; Gannon et al., 2011) (Figure 3). These effects
in mice also appear to reflect similar functions in humans
because a polymorphism in p53 that reduces p53 function
increases cancer incidence and life span in humans (van Heemst
et al., 2005). This suggests that increased p53 activity protects
against cancer but can promote aging and shorten life span, at
least when a certain threshold of activity is reached.Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc. 153
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Figure 1. Multiple Sources of Damage to
Biological Macromolecules Reduce Stem
Cell Function during Aging
Sources of damage (top row) including ROS,
exogenous mutagens, proliferation, infidelity of
DNA replication, and errors in protein translation
can damage macromolecules or organelles within
a cell (middle row). Damage accumulates in DNA,
proteins, mitochondria, and lipids during aging
and contributes to declines in stem cell function,
tissue regeneration, and life span. The cellular
consequences of this damage (bottom row)
include cell death, cellular senescence, differenti-
ation, altered cellular physiology, and cancer. All of
these mechanisms are interrelated; damage to
one component, such as telomeres, can influence
the function of other components, such as mito-
chondria (Sahin and Depinho, 2010).
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sors depend on expression level and context (Figure 3),
promoting the maintenance of mitotically active cells in some
contexts while promoting cell death or senescence in other
contexts. For example, p53 promotes the maintenance of
genomic integrity (Schoppy et al., 2010) and promotes tissue
regeneration in Atrmutant mice by promoting DNA repair and/or
by promoting the death of cells with DNA damage (Ruzankina
et al., 2009); however, in response to oncogenic stimuli or telo-
mere attrition, p53 depletes stem cells (Begus-Nahrmann
et al., 2009; Lee et al., 2010). Increased p53 function in HSCs
reduces proliferative potential but slows the expression of
somemolecular markers of aging (Chambers et al., 2007). More-
over, transgenic mice that constitutively express moderately
increased levels of p15Ink4b, p16Ink4a, p19Arf, and/or p53 exhibit
no signs of accelerated aging and may even show increased
median life span that cannot be explained by reduced cancer
incidence (Garcı´a-Cao et al., 2002; Matheu et al., 2004, 2007).
Not all normal cell proliferation in aging tissues is advantageous,
as illustrated by atherosclerosis. Therefore, cancer suppression
may not be the only function of gate-keeping tumor suppressors
in aging stem/progenitor cells, as these tumor suppressors
might also help sustain tissue homeostasis by suppressing
pathological or dysplastic proliferation, or aberrant differentia-
tion, in aging tissues.
p16Ink4a and p14Arf may also regulate human aging. A series of
genome-wide association studies have found significant associ-
ations between polymorphisms in or near the p16Ink4a/p14Arf
locus in humans and the risk of age-related diseases, including
type 2 diabetes and heart disease (Jeck et al., 2012). However,
it is not clear whether the polymorphisms increase or decrease
p16Ink4a/p14Arf function. Overall, gate-keeping tumor suppres-
sors have pleiotropic functions that promote stem cell function
in some ways and negatively regulate stem cell function in other
ways, with complex and context-dependent consequences for
aging.154 Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc.Care-Taking Tumor Suppressors
and Genomic Integrity
Care-taking tumor suppressors, includ-
ing DNA repair pathway components,
promote stem cell function and tissue
regeneration by maintaining genomicintegrity (Kinzler and Vogelstein, 1997). Various forms of DNA
damage accumulate throughout life as a result of DNA replica-
tion errors, exposure to endogenous mutagens such as reactive
oxygen species (ROS), and exposure to exogenous mutagens
such as UV light. To attenuate the accumulation of mutations,
a DNA damage response network can sense DNA damage and
activate a variety of repair mechanisms, including nucleotide
excision repair, mismatch repair, nonhomologous end joining,
and homologous recombination (Ciccia and Elledge, 2010). Acti-
vation of the DNA damage response network can transiently halt
the cell cycle and repair damaged DNA through p53-dependent
mechanisms. If the damage is too extensive to be repaired, the
network can trigger the onset of senescence or cell death to
eliminate the cells. Abundant cell death and senescence,
however, can lead to tissue degeneration. Alternatively, unre-
paired DNA damage can lead to the development of cancer,
the incidence of which rises dramatically with age.
DNA repair pathway components thus delay cellular aging
by maintaining genomic integrity. A number of single gene
mutations that impair DNA repair cause segmental progeria
syndromes. Segmental progeria syndromes are rare human
diseases defined by reduced life span and premature aging
phenotypes, including cataracts, osteoporosis, skin atrophy,
hair graying, heart disease, cancer, cerebellum degeneration,
and immunodeficiency. Segmental progeria syndromes caused
by defects in DNA repair include Werner syndrome, a recessive
trait caused by loss of function in the RecQ DNA helicase
WRN, and Ataxia Telangiectasia, a recessive trait caused by
loss of function in the DNA damage signaling protein ATM
(Martin, 2005). Mice engineered to carry mutations in the genes
associated with human progeroid syndromes similarly display
phenotypes consistent with accelerated aging (Wong et al.,
2003; Chang et al., 2004). The observation that progeria
syndromes are frequently caused by defects in DNA repair
suggests that DNA damage may be a fundamental underlying
cause of aging.
p19Arf p16Ink4a
Cyclin D 
Cdk4/6 
Rb Rb 
P 
P P 
E2F 
Rb
E2F 
Senescence Cell Cycle Progression
Mdm2 
p53 p21Cip1
Apoptosis 
Polycomb
(Bmi-1, Ezh2) 
let-7 Hmga2 JunB p16
Ink4a/
p19Arf
Stem Cell
Function
Aging 
A 
B 
Differentiation 
Figure 2. Heterochronic Genes Regulate
Increases in the Expression of Gate-
Keeping Tumor Suppressors and Declines
in Aging Stem Cell Function
Stem cell self-renewal and stem cell aging are
regulated by networks of proto-oncogenes (green)
and tumor suppressors (red).
(A) let-7 microRNA is an evolutionarily conserved
heterochronic gene that regulates the timing
of developmental events from C. elegans to
mammals (Pasquinelli et al., 2000). let-7b expres-
sion increases with age in mammals, reducing the
expression of the Hmga2 chromatin-associated
factor, and increasing the expression of the JunB,
p16Ink4a, and p19Arf tumor suppressors (Nishino
et al., 2008). The increase in p16Ink4a expression
during aging reduces stem cell function in multiple
tissues (Janzen et al., 2006; Krishnamurthy et al.,
2006; Molofsky et al., 2006). let-7 microRNA also
increases with age in Drosophila, acting in the
niche to non-cell-autonomously reduce sper-
matogonial stem cell function by impairing the
secretion of Unpaired (Toledano et al., 2012).
(B) p16Ink4a and p19Arf expression are also
repressed in mammalian stem cells by polycomb
proteins, including Bmi-1 and Ezh2 (Jacobs et al.,
1999; Lessard and Sauvageau, 2003; Molofsky
et al., 2003; Park et al., 2003; Chen et al., 2009b).
In the absence of Bmi-1, p16Ink4a and p19Arf
expression are induced in postnatal stem cells
from multiple tissues, inducing cell death, cellular
senescence, or premature differentiation. These pathways illustrate how networks of proto-oncogenes and tumor suppressors regulate stem cell maintenance
and homeostasis in adult tissues. The way in which proto-oncogenic and tumor suppressor signals are balanced within these networks changes with age in
stem cells.
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components exhibit stem cell defects in multiple tissues. Loss
of the DNA damage sensor ATM depletes HSCs (Ito et al.,
2004), exacerbates the loss of melanocyte stem cells in
response to low dose radiation (Inomata et al., 2009), and
promotes the loss of undifferentiated spermatogonia (Takubo
et al., 2008). Loss of a related DNA damage sensor, ATR,
depletes HSCs and hair follicle stem cells (Ruzankina et al.,
2007). Mice deficient in nucleotide excision repair (XpdTTD),
mismatch repair (Msh2/), nonhomologous end joining
(Lig4(Y288C) and Ku80/), or homologous recombination
(Brca2/) all exhibit reduced HSC function (Reese et al., 2003;
Navarro et al., 2006; Nijnik et al., 2007; Rossi et al., 2007). The
mechanism by which deficiency for DNA repair genes depletes
stem cells involves accumulation of DNA damage, induction of
p53 and p21cip1 (Merritt et al., 1994; Choudhury et al., 2007;
Takubo et al., 2008; Begus-Nahrmann et al., 2009), elevated
ROS levels (Ito et al., 2004), and premature differentiation (Ino-
mata et al., 2009; Wang et al., 2012).
DNA damage accumulates with age in HSCs and epidermal
stem cells from mice (Rossi et al., 2007; Sotiropoulou et al.,
2010). It remains to be determined whether the amount of DNA
damage that accumulates with age in normal stem cells actually
contributes to declines in stem cell function under physiological
conditions. However, DNA damage in stem cells may nonethe-
less have profound consequences. Most somatic cells are post-
mitotic and are therefore unlikely to be transformed into cancer
cells by mutations or to pass their mutations onto progeny.
Most dividing cells are short-lived and therefore produce
a limited number of progeny or do not persist long enough to
accumulate mutations over time. In contrast, stem cells remainmitotically active throughout life, generating large numbers of
progeny in some tissues. Given that transformation of normal
cells into cancer cells requires a series of mutations that accu-
mulate over a period of years, the ability of stem cells to accumu-
late mutations and then expand the pool of mutated cells may be
critical for the evolution of cancer in regenerative tissues (Rossi
et al., 2008). Nonetheless, this does not mean that most cancers
arise from stem cells. Even if most carcinogenic mutations accu-
mulate in stem cells, the finalmutation that causes frank transfor-
mation may occur in the numerically expanded restricted
progenitors or differentiated cells that arise from stem cells.
Telomeres
Telomeres are specialized nucleoprotein caps that contain thou-
sands of base pairs of repetitive DNA sequences that protect the
ends of chromosomes from end-to-end fusions that induce DNA
damage responses (Palm and de Lange, 2008; Sahin and
Depinho, 2010). Because of the way DNA is replicated, telo-
meres shorten with each round of cell division such that the repli-
cative potential of cells is limited by the length of their telomeres,
unless the cells express telomerase, which can lengthen telo-
meres and increase replicative capacity. Telomeres shorten
with age in many human cells, including HSCs (Vaziri et al.,
1994, and references therein). When telomeres reach a critically
short length, cells can exhibit genomic instability and undergo
cell cycle arrest, senescence, or apoptosis (Chin et al., 1999;
Choudhury et al., 2007; Begus-Nahrmann et al., 2009; Sperka
et al., 2012). In addition to protecting against genomic instability,
p53 activation following telomere dysfunction also impairs mito-
chondrial biogenesis, mitochondrial activity, andmetabolic func-
tion (Sahin et al., 2011). It has been proposed that cellular agingCell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc. 155
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Figure 3. The Multifaceted and Context-Dependent Effects of p53 in
Stem Cells
The consequences of tumor suppressor expression in stem cells can be
context dependent. p53 can have both positive (blue) and negative (red)
effects on stem cell function, depending on context and expression level.
When expressed at low levels, p53 can promote stem cell maintenance by
promoting the maintenance of genomic integrity and by regulating metabo-
lism. When expressed at high levels, p53 can promote stem cell depletion
through cell death or cellular senescence. The aggregate effect of these
functions influences longevity, cancer incidence, and tissue regeneration
during aging (Tyner et al., 2002; TeKippe et al., 2003; van Heemst et al., 2005;
Dumble et al., 2007; Schoppy et al., 2010; Gannon et al., 2011).
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damage and loss of replicative potential that ensue (Harley et al.,
1992).
Most human cells do not express telomerase, though telome-
rase is commonly expressed in cancer cells and other immortal-
ized cells (Kim et al., 1994). Loss of telomerase function in mice
reduces the regenerative capacity of proliferative organs (Lee
et al., 1998), accelerates the development of aging phenotypes
(like hair graying), reduces life span, and increases cancer inci-
dence (particularly in the absence of p53) (Blasco et al., 1997;
Rudolph et al., 1999; Artandi et al., 2000). Telomerase-deficient
mice exhibit defects in stem cell function in the forebrain,
epidermis, intestinal epithelium, and hematopoietic system
through cell-autonomous (Lee et al., 1998; Allsopp et al., 2003;
Choudhury et al., 2007; Ferro´n et al., 2009; Jaskelioff et al.,
2011) and non-cell-autonomous effects on stem cells (Ju et al.,
2007). HSCs express telomerase (Morrison et al., 1996a), slow-
ing, but not eliminating, the decline in telomere length with age
(Vaziri et al., 1994). An important caveat is that profound defects
are not apparent in germline telomerase-deficient mice for
three generations after they are generated because inbred
mice have relatively long telomeres (Kipling and Cooke, 1990).
This suggests that telomerase is not required during a single
generation in inbred mice under normal circumstances. In
contrast, telomere length in young zebra finches is predictive
of life span (Heidinger et al., 2012), suggesting that telomere
length may limit life span in some species. This raises the ques-
tion of whether telomere length limits proliferative potential
during a normal human life span or whether telomere length
only becomes limiting in the context of conditions that promote
chronic tissue regeneration.
Defects in human telomerase function cause diseases with
features of premature aging, including impaired regeneration of156 Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc.proliferative tissues (Lansdorp, 2009). Dyskeratosis congenita
is a rare form of ectodermal dysplasia caused by very short
telomeres that result from loss-of-function mutations in telome-
rase components or telomere binding proteins (reviewed by
Walne and Dokal, 2009). Indeed, loss-of-function mutations in
only a single copy of telomerase lead to accelerated telomere
shortening and reduced tissue regeneration (Hao et al., 2005).
Accelerated shortening of telomeres has also been observed in
other conditions with premature aging phenotypes, including
trisomy 21 (Vaziri et al., 1993). Telomere preservation is thus
a key aspect of genomic integrity in which defects impair regen-
eration and accelerate aging.
Oxygen, Energy Metabolism, and ROS
Aging is proposed to result from cellular damage caused by
free radicals, principally ROS generated as a consequence
of oxidative phosphorylation in the mitochondrial electron trans-
port chain (Wallace, 2005). ROS, such as superoxide and
hydroxyl radical, are highly reactive and can damage mitochon-
drial and nuclear DNA, as well as proteins and lipids, by
chemically modifying them. Oxidized macromolecules, such as
8-hydroxy-2-deoxyguanosine, accumulate with age in rats
(Fraga et al., 1990). Increased expression of enzymes such as
superoxide dismutases or catalase, which convert ROS into
less reactive or nonreactive species, reduce the accumulation
of oxidized macromolecules, increase maximum life span, and
decrease the incidence of certain diseases of aging, including
cancer (Wallace, 2005).
Stem cells appear to be particularly sensitive to elevated ROS
levels. Under normal conditions, ROS can function as signaling
molecules that regulate the differentiation of stem/progenitor
cells, such as in Drosophila hematopoietic cells (Owusu-Ansah
and Banerjee, 2009). However, ROS levels increase in HSCs
with age, and prolonged treatment with the antioxidant
N-acetyl-L-cysteine increases the replicative potential of HSCs
upon serial transplantation in irradiated mice (Ito et al., 2006).
Overexpression of superoxide dismutase in either stem cells or
their supporting cells in the niche can prolong stem cell function
during aging, as shown by work performed in the Drosophila
ovary (Pan et al., 2007b).
Although the consequences of elevated ROS for stem cell
function have been widely studied, we have only glimpses of
how ROS levels are regulated in stem cells. FoxO transcription
factors regulate metabolism and oxidative stress, partly by
promoting the expression of antioxidant enzymes (Salih
and Brunet, 2008). Conditional deletion of FoxO1, FoxO3, and
FoxO4 in mice increases ROS levels and depletes HSCs and
neural stem cells (Tothova et al., 2007; Paik et al., 2009). Treat-
ment with N-acetyl-L-cysteine partially rescues the stem cell
defects in these mice. FoxO3 appears to be particularly impor-
tant, because deficiency for FoxO3 alone leads to oxidative
stress and depletion of HSCs and neural stem cells (Miyamoto
et al., 2007; Yalcin et al., 2008; Renault et al., 2009). Multiple
other mechanisms promote stem cell maintenance at least partly
by regulating oxidative stress, including the transcription factor
Prdm16 (Chuikov et al., 2010), the polycomb family chromatin
regulator, Bmi-1 (Liu et al., 2009a), and the DNA damage
signaling molecule ATM (Ito et al., 2004; Maryanovich et al.,
2012). There are likely to be many additional transcriptional
Cell Stem Cell
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response to ROS.
Consistent with the sensitivity of stem cells to ROS, responses
to oxygen levels and mitochondrial function are highly regulated
in stem cells. The Hypoxia inducible factor 1a (Hif1a) transcrip-
tion factor regulates stem cell function and aging. Under nor-
moxic conditions, the E3 ubiquitin ligase von Hippel Lindau
(VHL) targets Hif1a for degradation (Majmundar et al., 2010).
However, Hif1a is stabilized in low oxygen conditions, activating
the transcription of heat shock proteins, glucose transporters,
and glycolytic enzymes that allow a cell to survive in a low
oxygen environment. Some hematopoietic and neural stem cells
are thought to reside in hypoxic microenvironments (Parmar
et al., 2007), and Hif1a is stabilized within these cells to promote
their maintenance. Deficiency for Hif1a depletes neurogenic
progenitors in the dentate gyrus and HSCs during aging
(Mazumdar et al., 2010; Takubo et al., 2010). However, increased
stabilization of Hif1a by reduced VHL function also impairs HSC
function, suggesting that Hif1a levels must be tightly controlled
for stem cell maintenance (Takubo et al., 2010).
Mitochondrial function is regulated in concert with ROS levels.
For example, the PGC-1 transcriptional coactivator is a potent
activator of mitochondrial biogenesis and oxidative phosphory-
lation (Puigserver et al., 1998). To avoid inducing oxidative
stress, PGC-1 also promotes the expression of ROS-detoxifying
enzymes, including GPx1 and SOD2 (St-Pierre et al., 2006).
Overexpression of PGC-1 in Drosophila intestinal stem cells is
sufficient to increase life span in flies, delaying age-related
changes in the intestine and improving tissue homeostasis
during aging (Rera et al., 2011). The authors of this study specu-
lated that PGC-1 function within stem cells may be an important
determinant of aging and longevity. This idea has not yet been
tested in mammals.
Defects in mitochondrial function, such as those caused by an
error-prone mitochondrial DNA polymerase, can also accelerate
aging phenotypes and reduce life span (Trifunovic et al., 2004).
The progeroid phenotypes in these mice include defects in the
function of hematopoietic and neural progenitors that can be
partially rescued by N-acetyl-L-cysteine treatment (Norddahl
et al., 2011; Ahlqvist et al., 2012). But while these studies demon-
strate that mitochondrial defects can lead to phenotypes that
are reminiscent of premature aging, they do not necessarily
demonstrate that mutations to mitochondrial DNA are a mecha-
nism underlying physiological aging because the rate of mito-
chondrial DNA mutations in aging wild-type mice is 500-fold
lower than in the mitochondrial mutator mice (Vermulst et al.,
2007).
Non-Cell-Autonomous Regulation of Cellular Aging
Extrinsic factors in the stem cell microenvironment regulate stem
cell aging. Stem cells typically reside in specialized microenvi-
ronments that promote stem cell maintenance and regulate
stem cell function (Morrison and Spradling, 2008). Aging of the
niche cells can cause changes in stem cell function. In
Drosophila, the number of germline stem cells, their mitotic
activity, and the number of progeny all decline with age due to
both cell autonomous and non-cell-autonomous changes
(Wallenfang et al., 2006; Pan et al., 2007b). In the male testis,
these changes are partially caused by changes within the niche,as hub cells from older animals express reduced levels of
DE-cadherin and Unpaired, both of which are necessary for
germline stem cell maintenance (Boyle et al., 2007). Reduced
Unpaired expression is caused partly by an increase in mRNA
degradation from let-7-targeting of IGF-II messenger RNA
binding protein (IMP) expression in aging hub cells (Toledano
et al., 2012). Overexpression of Unpaired in the hub cells of older
males rescues the age-related decline in germline stem cell
frequency (Boyle et al., 2007). Similarly, in the Drosophila ovary,
E-cadherin and BMP expression within the niche decline with
age, and genetically increasing expression can enhance the
function of old stem cells (Pan et al., 2007b).
Work on muscle stem cells (a subpopulation of satellite cells)
suggests that similar age-related changes in the microenviron-
ment within mammalian tissues, as well as in circulation, reduce
somatic stem cell function. Aging is associated with a reduced
capacity for muscle regeneration after injury, partly as a result
of reduced expression of Notch ligand by satellite muscle cells,
which reduces satellite cell proliferation after injury (Conboy
et al., 2003). Aging muscles also produce elevated levels of
TGF-b, which impedes regeneration and satellite cell prolifera-
tion (Carlson et al., 2008). However, exposure of old mice
to young systemic factors by making old and young mice
parabiotic can rejuvenate stem cell function (Conboy et al.,
2005). Exposure of satellite cells from old mice to serum from
young mice increases Notch ligand expression and proliferation
(Conboy et al., 2005). This demonstrates that age-related
changes in stem cells are partially reversible and influenced by
circulating factors that change with age.
A combination of cell-autonomous and non-cell-autonomous
mechanisms regulate the aging of stem cells in other tissues
as well. Within the nervous system astrocytes and neural stem
cells in the dentate gyrus promote the self-renewal of stem
cells and the expansion of neuroblasts by secreting Wnts
(Song et al., 2002; Lie et al., 2005). Expression of the Wnt antag-
onist Dkk1 increases in the aging dentate gyrus, and conditional
deletion of Dkk1 from neural stem and progenitor cells increases
neural stem cell self-renewal, neurogenesis, and spatial learning
and memory in old mice (Seib et al., 2013).
Circulating blood-borne factors also regulate changes in stem
cell function in the aging central nervous system where stem cell
frequency, overall mitotic activity, and rates of neurogenesis
decline profoundly with age in the mouse forebrain (Kuhn et al.,
1996;Maslov et al., 2004; Molofsky et al., 2006). In heterochronic
parabionts, rates of neurogenesis and other measures of neural
function decline in the young parabiont and increase in the old
parabiont (Villeda et al., 2011). These effects appear to be
partially explained by an age-related increase in the level of
CCL11 chemokine in the plasma, which is sufficient to reduce
neurogenesis, learning, and memory when administered to
young mice. Heterochronic parabiosis also enhances the rate
of remyelination after experimentally induced demyelination in
old mice, a process that normally declines with age (Ruckh
et al., 2012). The enhanced remyelination is associated with the
recruitment of blood monocytes from the young parabiont, sug-
gesting that the young circulating agents that enhance the regen-
eration of aging tissues can be cellular as well as soluble factors.
The circulating hormones insulin and insulin-like growth factor
1 (Igf1) also regulate aging and stem cells. The insulin/Igf1Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc. 157
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Figure 4. Many Components of the Insulin/
PI3K Signaling Pathway Regulate Stem Cell
Function and Aging
A variety of tyrosine kinase receptors, including
the insulin receptor, activate the PI3K pathway,
which leads to the activation of both mTORC1
and mTOCR2 (Laplante and Sabatini, 2012).
mTORC2 can phosphorylate and activate Akt,
SGK, and protein kinase C (PKC). Activated Akt
can phosphorylate FoxO transcription factors,
restricting their localization to the cytosol. FoxOs
that translocate to the nucleus can transcrip-
tionally activate the expression of a variety of
genes, including protein folding chaperones,
antioxidant enzymes, and metabolic regulators
(Salih and Brunet, 2008). Activated Akt can also
activate mTORC1 by phosphorylating TSC2,
which relieves the inhibitory effects of the TSC1/
TSC2 complex on Rheb. mTORC1 activates
mechanisms that promote protein translation and
lipid and nucleic acid synthesis and inhibit auto-
phagy. The components of these pathways that
have not yet been studied in stem cells are likely to
regulate stem cell function and perhaps even stem
cell aging.
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response to nutrient availability by activating the phosphatidyli-
nositol-3-kinase (PI3K) signaling pathway and inactivating
FoxO transcription factors. In C. elegans, mutations in daf-2
(an IGFR ortholog) or other downstream signaling components
extend life span in a manner that depends upon daf-16
(a FoxO ortholog) (Kenyon et al., 1993; Lin et al., 1997; Ogg
et al., 1997). In Drosophila, reducing insulin signaling by ablating
insulin receptors, insulin receptor substrates, insulin producing
cells, or overexpression of dFOXO all extend life span (Clancy
et al., 2001; Tatar et al., 2001; Broughton et al., 2005; Giannakou
et al., 2007). Homozygosity for a polymorphism in FOXO3A is
associated with longevity in humans (Willcox et al., 2008). Mice
with reduced insulin or Igf1 signaling, systemically or only in
certain tissues, all exhibit slowed aging and increased life span
(Tatar et al., 2001). The ability of the insulin signaling pathway
to regulate aging and life span is thus evolutionarily conserved
(Tatar et al., 2003).
Insulin signaling is known to regulate stem cells, though stem
cell aging in long-lived mutants has not yet been closely exam-
ined. In Drosophila, reduced insulin signaling leads to declines
in germline stem cell proliferation and fecundity (LaFever and
Drummond-Barbosa, 2005), though data on mammalian stem
cells are surprisingly limited. It will be interesting to determine
whether long-lived insulin pathway mutants have increased
stem cell function and regenerative capacity in aging tissues.
The accumulation of senescent cells in aging tissues can also
non-cell-autonomously affect the function of other cells. Senes-
cence is a cellular state associated with an irreversible loss in the
ability to divide. Senescent cells undergo a series of changes,
including the secretion of inflammatory factors, growth regula-
tors, proteases, and other signaling molecules (Coppe´ et al.,
2010). These secreted factors affect other cells in the local
environment, promoting senescence and inflammation and158 Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc.promoting or inhibiting tumor growth. Life-long clearance of
senescent cells from adult mouse tissues resulting from genetic
ablation of p16Ink4a-expressing cells delays the onset of pathol-
ogies in multiple aging tissues (Baker et al., 2011). Clearance of
senescent cells only late in life did not improve age-related
pathologies but did attenuate their progression. This raises the
question of the extent to which p16Ink4a non-cell-autonomously
or cell-autonomously influences stem cell function in aging
tissues.
Dietary Restriction and TOR Signaling
Dietary restriction, defined as reducing food intake below ad libi-
tum (free feeding) levels without causing malnutrition, extends
life span in certain contexts while also delaying the onset of
age-related pathologies (Mair and Dillin, 2008). Dietary restric-
tion can also increase stem cell function or slow the decline in
stem cell function during aging in multiple tissues (Lee et al.,
2000; Mair et al., 2010). Short-term dietary restriction increases
the frequency and function of satellite cells in skeletal muscle
of both young and old mice, partly by increasing mitochondrial
content and promoting oxidative metabolism (Cerletti et al.,
2012). In at least one short-lived mouse strain, dietary restriction
attenuates age-related declines in HSC frequency and reconsti-
tuting activity (Chen et al., 2003). However, these effects of
dietary restriction may not be universal. Life span extension
was not observed in certain mouse strains (Harrison and Archer,
1987) and was observed in monkeys in one study (Colman et al.,
2009) but not in another (Mattison et al., 2012).
The effects of dietary restriction on aging and life span are
thought to occur partly through modulation of target of rapamy-
cin (TOR) signaling (Figure 4). TOR is a conserved serine/threo-
nine kinase that promotes protein synthesis and cellular growth
and is activated by signals that sense nutrient, growth factor,
amino acid, and energy availability (Laplante and Sabatini,
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Figure 5. Proteostasis Is Required for
Cellular Homeostasis during Aging
Proteostasis is regulated by protein translation
rates, which are controlled by ribosome bio-
genesis, recruitment, and loading. Chaperones
promote folding of nascent polypeptides or re-
folding of misfolded proteins to prevent protein
aggregation. Misfolded or damaged proteins can
be ubiquitylated and targeted for proteosomal
degradation or engulfed and degraded by auto-
phagosomes. Interventions that promote proteo-
stasis can slow aging, reduce the incidence of
age-related diseases, and increase life span
(Cohen et al., 2009; Durieux et al., 2011; Taylor
and Dillin, 2011). These mechanisms are likely
to influence tissue regeneration and stem cell
function during aging, but this remains largely
unstudied.
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complexes, TORC1 and TORC2, which contain the Raptor and
Rictor binding partners, respectively (Laplante and Sabatini,
2012). Activated TORC1 promotes protein synthesis by phos-
phorylating ribosomal protein S6 kinase 1 (S6K1), which acti-
vates ribosome biogenesis partly by phosphorylating the
ribosomal protein S6, and 4E-BP1, which frees eIF4E to bind
50-capped mRNAs, recruiting them to the ribosomal initiation
complex (Laplante and Sabatini, 2012) (Figure 4). In contrast,
TORC2 promotes cell growth, proliferation, survival, and aspects
of cellular metabolism by phosphorylating AKT (Sarbassov et al.,
2005), SGK (Garcı´a-Martı´nez and Alessi, 2008), and protein
kinase C (Guertin et al., 2006) (Figure 4). TOR therefore has
distinct functions in different signaling complexes.
Reduced TOR signaling, and TORC1 signaling in particular,
can slow organismal aging and extend life span (Figure 4). In
C. elegans, heterozygosity for the Raptor ortholog daf-15 signif-
icantly increases maximum life span (Jia et al., 2004). Reducing
the expression of various downstream targets of TORC1, such
as rsks-1 (an S6K1 ortholog), ifg-1 (eIF4G ortholog), and other
translation initiation complex factors, also extend C. elegans
life span (Hansen et al., 2007; Pan et al., 2007a). In mammals,
reduced mammalian TOR (mTOR) signaling also extends life
span, such as is observed upon feedingmice themTORC1 inhib-
itor rapamycin (Harrison et al., 2009). The beneficial effects of
rapamycin on longevity were evident even when treatment was
initiated at 270 days of age, suggesting that interventions late
in life can influence health and longevity. Mice that are deficient
for S6K1 also have increased life span and improved motor
function, T cell abundance, bone volume, and insulin sensitivity
in old age (Selman et al., 2009). TORC1 signaling is thus a key
regulator of aging.
TOR also regulates stem cell function (Figure 4). Dietary
restriction reducesmTOR signaling in Paneth cells (a component
of the intestinal stem cell niche), which non-cell-autonomously
increases the proliferation of intestinal stem cells (Yilmaz et al.,Cell Stem Cell 122012). Hyperactivation of mTORC1 and/
or mTORC2 by deletion of Pten or TSC1
aberrantly increases the proliferation of
neural stem/progenitor cells (Groszer
et al., 2001) and HSCs (Yilmaz et al.,2006; Zhang et al., 2006; Gan et al., 2008). However,
hyperactivation of mTOR in vivo leads to the depletion of some
adult neural stem cells (Bonaguidi et al., 2011) as well as HSCs
through mTORC1 and mTORC2-dependent mechanisms (Lee
et al., 2010; Kalaitzidis et al., 2012; Magee et al., 2012).
The studies described above would predict that reduced
mTOR signaling should also attenuate the decline in stem cell
function during aging. However, there remain little data on this
point. One study reported that mTORC1 signaling is increased
in HSCs isolated from old mice, and that age-related declines
in HSC reconstituting activity and lymphoid differentiation could
be rescued by rapamycin treatment (Chen et al., 2009a).
However, rapamycin treatment also increases HSC frequency
in young mice, raising questions about the extent to which these
effects reflected a rescue of aging phenotypes. Additional
studies examining the consequences of reduced mTOR
signaling in young and old stem cells are needed to address its
role in stem cell aging.
Proteostasis
Amajor challenge for aging cells is homeostasis of the proteome
(proteostasis) (Taylor and Dillin, 2011). Misfolded or damaged
proteins can disrupt membranes, form toxic aggregates, and
cause cell death (Bucciantini et al., 2002). Several age-related
diseases are associated with protein misfolding, including
Alzheimer’s disease, Parkinson’s disease, and Huntington’s
disease (Ross and Poirier, 2004). Emerging evidence suggests
that proteotoxic stress may be an underlying mechanism in
metabolic disorders such as diabetes and a determinant of life
span (Balch et al., 2008; Durieux et al., 2011; Vilchez et al.,
2012b).
A complex network of cellular machinery regulates proteosta-
sis by monitoring proteins throughout their life cycle (Figure 5).
The rate at which proteins are produced is tightly controlled by
stringent regulation of translation through control of ribosome
biogenesis, ribosome recruitment, and ribosome loading, February 7, 2013 ª2013 Elsevier Inc. 159
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regulated bymolecular chaperones, which trap nascent proteins
in tight binding pockets to assist folding, to prevent unwanted
aggregation, and to protect them from thermal or oxidative
stress (Hartl et al., 2011). Unneeded, misfolded, damaged, and
aggregated proteins can be eliminated by the ubiquitin protea-
some system (Finley, 2009) or through autophagy (Rubinsztein
et al., 2011). Each of these proteostasis mechanisms are
capable of eliminating damaged proteins or triggering a more
global response, such as cell cycle arrest or apoptosis in the
context of severe proteotoxic stress (Ron andWalter, 2007; Bou-
lon et al., 2010).
The accumulation of damaged proteins during aging suggests
that the capacity to regulate proteostasis declines with age.
Protein damage can occur bymisfolding, aggregation, glycation,
carbonylation, or oxidation, or from translation errors, genetic
mutations (Chiti et al., 2003), and reactive metabolites (Berlett
and Stadtman, 1997). Mutations and damage from reactive
metabolites accumulate with age. In addition, some proteostasis
mechanisms are known to decline during aging, including the
endoplasmic reticulum stress response (Ben-Zvi et al., 2009)
and autophagy (Rubinsztein et al., 2011). Furthermore, interven-
tions that promote proteostasis can slow aging, reduce the
incidence of age-related diseases, and increase life span (Cohen
et al., 2009; Durieux et al., 2011; Taylor and Dillin, 2011).
Decreasing translation by reducing ribosomal protein levels in
yeast increases replicative life span (Chiocchetti et al., 2007),
and reduced expression of a variety of translation initiation
factors increases life span in C. elegans (Pan et al., 2007a) and
mammals (Selman et al., 2009).
Many mechanisms that regulate aging and proteostasis also
regulate stem cells (Buckley et al., 2012; Vilchez et al., 2012a).
Autophagy is likely to be important for HSC maintenance,
because deletion of either Atg7 (Mortensen et al., 2011) or
Fip200 (Liu et al., 2010), both of which are necessary for auto-
phagy, increases ROS levels and depletes HSCs. FoxO, which
promotes longevity and stem cell function, transcriptionally acti-
vates the expression of multiple protein-folding chaperones
(Murphy et al., 2003; Oh et al., 2006; Demontis and Perrimon,
2010), some of which regulate aging (Tatar et al., 1997; Walker
and Lithgow, 2003; Morley and Morimoto, 2004); however, it is
unclear towhat extent the chaperones regulate stemcell function
or stem cell aging. FOXO4 promotes proteasome activity in
human embryonic stem cells, promoting proteostasis and main-
tenance of pluripotency (Vilchez et al., 2012a). In addition,
mTOR is a potent activator of protein translation and inhibitor of
autophagy (Laplante and Sabatini, 2012), but it is not clear to
what extent these proteostasis pathways mediate the effects of
mTOR on stem cell function or aging. It will be important
to characterize the mechanisms that regulate proteostasis in
stem cells to determine whether they differ from other cells and
whether they influencechanges in stemcell functionduringaging.
Conclusions
Many aspects of cellular physiology are regulated differently in
stem cells as compared to other kinds of cells (He et al., 2009).
Some regulators of stem cell self-renewal are broadly required
bymany types of dividing cells while other key self-renewal regu-
lators do not regulate the proliferation of restricted progenitors in160 Cell Stem Cell 12, February 7, 2013 ª2013 Elsevier Inc.the same tissues. This suggests that some mechanisms that
regulate stem cell aging may broadly regulate the aging of
many cells, while other mechanisms will preferentially regulate
stem cell aging. So far, the data suggest that the mechanisms
that promote the onset of aging phenotypes in other cells (DNA
damage, ROS, proteotoxicity, circulating factors from old
mice, and telomere erosion) also reduce stem cell function in
a manner that is consistent with premature aging, at least in
certain tissues (Figure 1). Nonetheless, the details of how these
mechanisms influence stem cells may differ from how they influ-
ence restricted progenitors and postmitotic cells. For example,
gate-keeping tumor suppressors may regulate different cells in
different ways, potentially slowing the onset of aging phenotypes
in some cells while accelerating aging phenotypes in others. It is
not surprising that such mechanisms would influence dividing
and nondividing cells in different ways; however, there are also
likely to be less obvious differences in how these mechanisms
influence stem cells versus restricted progenitors.
There are also likely to be important undiscovered mecha-
nisms, including those that preferentially regulate stem cell
aging. For example, there is a centrosome orientation check-
point in Drosophila that prevents spermatogonial stem cells
from dividing unless the centrosomes align in a way that facili-
tates asymmetric division (Cheng et al., 2008). The frequency
of stem cells with misaligned centrosomes increases with age,
reducing stem cell activity and spermatogenesis. While this is
a major cause of the physiological decline in spermatogenesis
that occurs with age in flies it remains uncertain whether a similar
checkpoint contributes to mammalian stem cell aging. This work
illustrates the existence of previously unsuspected mechanisms
that regulate declines in stem cell function with age, and that do
not fit neatly into the themes emphasized by common theories of
aging. Much work remains to be done to understand the mech-
anisms that regulate stem cell aging. Elucidating these mecha-
nisms will be critical to understanding how regenerative capacity
is preserved in certain tissues throughout adult life, and why that
capacity declines with age.
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